Sibila, O., Laserna, E., Maselli, D.J., Fernandez, J.F., Mortensen, E.M., Anzueto, A., Waterer, G. and Restrepo, M.I. (2015) Risk Factors and Antibiotic Therapy in P. aeruginosa Community-Acquired Pneumonia. Respirology, 20, 660-666.
http://dx.doi.org/10.1111/resp.12506

has been cited by the following article:

• TITLE: Pseudomonas aeruginosa Community Acquired Pneumonia with Septicemia in a Previously Healthy Woman

  AUTHORS: Yoshiro Imai, Ryo Iida, Masahiko Nitta, Akira Takasu

  KEYWORDS: Pseudomonas aeruginosa, Community Acquired Pneumonia, Septicemia

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.5 No.9, September 29, 2016

  ABSTRACT: A previously healthy 53-year-old woman was urgently hospitalized due to septic shock. She was diagnosed with bacterial pneumonia based on chest radiograph and computed tomography findings of right upper lobe consolidation. Sputum Gramstain at the time of admission showed gram-negative rods with phagocytosis. Intravenous meropenem was immediately initiated as empiric antibacterial therapy. Bacterial culture specimens from sputum and blood were positive for Pseudomonas aeruginosa. Following appropriate antibiotic therapies, the patient recovered from a shock state and gradually became well. There has been no evidence of recurrence at 6 months after discharge. P. aeruginosa community acquired pneumonia with septicemia is rapidly progressive and often fatal. The choice of initial empiric antibiotic treatment that is active against P. aeruginosa is critical in improving outcome.